Condition: Ulcerative Colitis · Ulcerative Colitis Chronic · Inflammatory Bowel Diseases · Sponsor: Eli Lilly and Company
The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks and may include up to 44 visits. Additional treatment may be available to participants via a Continued Access Period.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| UCSF Medical Center at Mission Bay | San Francisco, California, United States | Recruiting |
| Connecticut Children's Medical Center | Hartford, Connecticut, United States | Recruiting |
| Emory University School of Medicine | Atlanta, Georgia, United States | Recruiting |
| Children's Center for Digestive Health Care, LLC | Atlanta, Georgia, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Massachusetts General Hospital | Waltham, Massachusetts, United States | Recruiting |
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Children's Hospital of Philadelphia (CHOP) | Philadelphia, Pennsylvania, United States | Not Yet Recruiting |
| Cook Children's Medical Center | Fort Worth, Texas, United States | Recruiting |
| Pediatric Specialists of Virginia | Fairfax, Virginia, United States | Not Yet Recruiting |
| Medizinische Universität Wien | Vienna, Austria | Not Yet Recruiting |
+ 56 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04844606